Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07585591 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments
A NA study, sponsored by CynosureLutronic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07585591 is a NA study that has completed, run by CynosureLutronic. The registered enrollment target is 40 participants.
The verdict
NCT07585591, a NA study, has completed, sponsored by CynosureLutronic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical study is to evaluate the safety and clinical effectiveness of the XERF noninvasive dual-frequency monopolar radiofrequency device for aesthetic improvement of facial aging, including fine lines and wrinkles, eyebrow lifting, and tightening of lax tissue in the lower face, submental area, and neck in healthy adults. Up to 60 participants may be enrolled across up to five clinical sites in the United States. Participants receive XERF treatments using 6.78 MHz and 2.0 MHz energy; most undergo two sessions approximately four weeks apart (the protocol allows up to three). Standardized photographs are taken at baseline and follow-up visits. Outcomes are assessed approximately 30 and 90 days after the final treatment. Effectiveness is evaluated using investigator-assessed global aesthetic improvement and participant-reported satisfaction, while safety and tolerability are assessed through procedural pain ratings and monitoring of adverse events throughout the study.
Interventions
- DEVICE Noninvasive dual-frequency monopolar radiofrequency
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2025-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07585591
The ClinicalTrials.gov registry entry for NCT07585591 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CynosureLutronic, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Noninvasive dual-frequency monopolar radiofrequency is the first listed.
NCT07585591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07585591 about?
NCT07585591 is a clinical study titled "Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments". The goal of this clinical study is to evaluate the safety and clinical effectiveness of the XERF noninvasive dual-frequency monopolar radiofrequency device for aesthetic improvement of facial aging, including fine lines and wrinkles, eyebrow lifting, and tightening of lax tissue in the lower face, s...
What is the current status of trial NCT07585591?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-20. Estimated completion is 2025-08-12.
What interventions are being tested in trial NCT07585591?
The interventions under investigation include: Noninvasive dual-frequency monopolar radiofrequency (DEVICE).
Who is sponsoring clinical trial NCT07585591?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.